Scarica l'app Stockscreener
7.12
4.86%
0.33
Dopo l'orario di chiusura:
7.16
0.04
+0.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$6.79
Aprire:
$6.85
Volume 24 ore:
2.97M
Relative Volume:
1.26
Capitalizzazione di mercato:
$1.88B
Reddito:
$9.47B
Utile/perdita netta:
$-178.00M
Rapporto P/E:
-14.83
EPS:
-0.48
Flusso di cassa netto:
$1.01B
1 W Prestazione:
+11.60%
1M Prestazione:
+58.93%
6M Prestazione:
-10.33%
1 anno Prestazione:
+0.14%
Intervallo 1D:
$6.815
$7.235
Intervallo di 1 settimana:
$6.375
$7.235
Portata 52W:
$3.96
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Nome
Bausch Health Companies Inc
Settore
Telefono
514-744-6792
Indirizzo
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Confronta BHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.12 | 1.88B | 9.47B | -178.00M | 1.01B | -0.48 |
|
RGC
Regencell Bioscience Holdings Ltd
|
10.36 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.08 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.26 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-02 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Iniziato | Raymond James | Mkt Perform |
| 2023-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Downgrade | Truist | Buy → Hold |
| 2022-07-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Ripresa | JP Morgan | Overweight |
| 2021-03-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-24 | Iniziato | Citigroup | Buy |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Iniziato | Goldman | Neutral |
| 2019-10-25 | Iniziato | Cowen | Outperform |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-08-15 | Aggiornamento | TD Securities | Hold → Buy |
| 2019-07-19 | Iniziato | Wolfe Research | Outperform |
| 2019-06-11 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-01-02 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Aggiornamento | Piper Jaffray | Underweight → Neutral |
Mostra tutto
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Bausch + Lomb Brief: Prices Upsized Senior Secured Notes Offering - MarketScreener
GMS Posts Upbeat Earnings, Joins Coinbase Global, Genworth Financial, Sandisk And Other Big Stocks Moving Higher On Wednesday - Benzinga
Bausch Health ticks higher following large director stock purchase - MSN
John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - The Globe and Mail
Director buying at Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha
Bausch Health Companies Inc. (TSE:BHC) Director John Paulson Acquires 754,134 Shares - MarketBeat
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Yahoo Finance
LOOK: These 10 Stocks Just Stole The Show - Insider Monkey
Bausch Health (BHC) Rises After Director's $15M Share Purchase - GuruFocus
Bausch Health Companies Stock Price, Quotes and Forecasts | NYSE:BHC - Benzinga
Hedge Fund and Insider Trading News: Philippe Laffont, Warren Buffett, Bill Ackman, Farallon Capital, Bausch Health Companies Inc (BHC), MicroStrategy Inc (MSTR), and More - Insider Monkey
Rising Demand in Traveler's Diarrhea MarketTop Developments, - openPR.com
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA
Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets - The Globe and Mail
Benzodiazepine Drugs Market Trends, Growth Forecast, and Top - openPR.com
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com
Bausch + Lomb Brief: Launching Senior Secured Notes Offering and Refinancing Credit Agreement - marketscreener.com
Huntington's Disease Market Grows with Increased Genetic - openPR.com
Reconstructive Surgery Market Trends, Size & Growth Forecast - openPR.com
The most oversold and overbought stocks on the TSX - The Globe and Mail
Two Sigma Investments LP Boosts Holdings in Bausch Health Companies Inc. (NYSE:BHC) - Defense World
Why Is Bausch (BHC) Down 13% Since Last Earnings Report? - Yahoo Finance
Intraocular Lens Market Is Booming So Rapidly 2025-2032 -Bausch - openPR.com
With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance
Choroidal Neovascularization Market: Insights Into Retinal - openPR.com
Verteporfin Market Projected to Witness Increased UtilizationNovartis, Valeant Pharmaceuticals - openPR.com
Actinic Keratosis Market Poised Boom | Almirall, S.A, Bausch - openPR.com
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - Yahoo Finance
Bausch Health’s $7.9 Billion Refinancing Transaction - Global Legal Chronicle
Zacks Research Has Bearish Forecast for BHC Q2 Earnings - Defense World
Research Analysts Offer Predictions for TSE:BHC Q2 Earnings - Defense World
Equities Analysts Set Expectations for BHC Q3 Earnings - Defense World
Colonoscopy Bowel Preparation Drugs Market Detailed Analysis - openPR.com
Facial Injectable Market Forecasts Report 2025-2030, - GlobeNewswire
Bausch Health Companies IncEnters Agreements With Icahn, Paulson, Kavanagh GroupsSEC Filing - marketscreener.com
Bausch Health and Bausch + Lomb Brief: Cos Have Cited Amendment to Definitive Proxy Statement Relating to 2025 Annual Meeting of Shareholders On May 21, 2025 - marketscreener.com
Bausch + Lomb’s New Board Agreements Announced - TipRanks
Bausch Health Signs New Board Agreements - TipRanks
Bausch Health Companies Inc. (NYSE:BHC) Receives Average Rating of “Reduce” from Analysts - Defense World
Bausch Health Companies (TSE:BHC) Stock Price Up 1.4% – Time to Buy? - Defense World
Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com | FinancialContent - FinancialContent
Balyasny Asset Management L.P. Invests $97,000 in Bausch Health Companies Inc. (NYSE:BHC) - Defense World
Global Cataract Surgery Devices Market to grow at a CAGR of 5.50% - openPR.com
Bausch Health Companies Inc. (NYSE:BHC) Stake Lessened by Stifel Financial Corp - Defense World
Bausch, Mylan Settle Patent Suit Over Generic IBS Drugs - Law360
Bausch Health’s CFO Steps In as Interim CAO - TipRanks
India Ophthalmic Devices Market Forecast Report 2025-2033, - GlobeNewswire
Genital Herpes Treatment Market reached US$ 1,143.19 million - openPR.com
Bausch Health Companies Inc Azioni (BHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bausch Health Companies Inc Azioni (BHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Paulson John | Director |
Jun 12 '25 |
Buy |
5.47 |
1,005,376 |
5,499,407 |
29,227,643 |
| Paulson John | Director |
Jun 11 '25 |
Buy |
5.24 |
1,029,098 |
5,392,474 |
28,222,267 |
| Paulson John | Director |
Jun 10 '25 |
Buy |
5.05 |
754,134 |
3,808,377 |
27,193,169 |
| Carson Seana | EVP, General Counsel |
Dec 02 '24 |
Sale |
8.35 |
440 |
3,674 |
433,066 |
2.01%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):